Hospital
Wellington Regional Medical Center LLC
Wellington Regional Medical Center LLC was paid $10.75M by Medicaid between Jan 2018 and Dec 2024, across 140 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoWELLINGTON REGIONAL MEDICAL CENTER LLC
WELLINGTON, FL 33414
WELLINGTON, FL 33414
33aNPI1720078702assigned 10/21/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.75M
24GClaims409,227
24DCodes billed140
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#47 of 163
Median peer was paid$4.77M
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,131 | $541K | |
| 2019 | 79,028 | $1.46M | |
| 2020 | 64,454 | $1.23M | |
| 2021 | 77,032 | $1.96M | |
| 2022 | 87,703 | $2.83M | |
| 2023 | 50,548 | $1.89M | |
| 2024incomplete | 20,331 | $835K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 25,487 | 22,715 | $2.39M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 30,960 | 25,959 | $1.91M |
| G0378 | Hospital observation service, per hour | 12% | 5,190 | 2,108 | $1.32M |
| 36415 | Collection of venous blood by venipuncture | 9.9% | 33,862 | 23,523 | $1.06M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.7% | 4,901 | 4,183 | $718K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.1% | 9,688 | 5,964 | $654K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.4% | 4,311 | 3,590 | $579K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.3% | 2,812 | 2,526 | $247K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.8% | 3,862 | 1,283 | $192K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 6,556 | 5,869 | $163K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,820 | 1,238 | $103K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 562 | 500 | $94K |
128 more codes
| 59025 | Fetal non-stress test | <1% | 3,210 | $87K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,895 | $85K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,696 | $79K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,059 | $71K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,241 | $70K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 327 | $54K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 2,269 | $54K |
| 81001 | <1% | 11,878 | $50K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 8,141 | $48K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,512 | $37K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,067 | $36K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,375 | $34K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,765 | $33K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,811 | $33K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 370 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,046 | $28K |
| 80053 | Comprehensive metabolic panel | <1% | 17,845 | $25K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 898 | $25K |
| 73130 | <1% | 479 | $23K | |
| 81003 | <1% | 3,536 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,547 | $18K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,127 | $18K |
| 76801 | <1% | 2,188 | $17K | |
| 87070 | <1% | 728 | $16K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 931 | $16K |
| 82962 | <1% | 3,432 | $15K | |
| 81025 | <1% | 5,761 | $14K | |
| 73630 | <1% | 530 | $14K | |
| 76818 | <1% | 205 | $13K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 132 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,908 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,940 | $11K |
| 84112 | <1% | 93 | $11K | |
| 73610 | <1% | 428 | $10K | |
| 73564 | <1% | 529 | $10K | |
| A9270 | Non-covered item or service | <1% | 6,816 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 27,083 | $9K |
| 87077 | <1% | 1,051 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 450 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,658 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 458 | $6K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 354 | $5K |
| 70486 | <1% | 58 | $5K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,348 | $5K |
| 85027 | <1% | 3,367 | $5K | |
| 99499 | <1% | 102 | $5K | |
| 85610 | <1% | 5,478 | $5K | |
| 87634 | <1% | 813 | $5K | |
| 12011 | <1% | 55 | $5K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,201 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 192 | $5K |
| 73030 | <1% | 289 | $5K | |
| 85730 | <1% | 5,167 | $4K | |
| 86900 | <1% | 3,934 | $4K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,198 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,897 | $4K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,814 | $4K |
| 86850 | <1% | 3,180 | $4K | |
| 87186 | <1% | 693 | $4K | |
| 84484 | <1% | 6,850 | $4K | |
| 73110 | <1% | 156 | $3K | |
| 86901 | <1% | 3,934 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,988 | $3K |
| 93971 | <1% | 291 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 271 | $2K |
| 72131 | <1% | 15 | $2K | |
| 72100 | <1% | 209 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 622 | $2K |
| 87040 | <1% | 1,907 | $2K | |
| 83690 | <1% | 6,982 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 168 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,106 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,670 | $1K |
| 74018 | <1% | 36 | $1K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,164 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 220 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 596 | $1K |
| 83735 | <1% | 2,922 | $1K | |
| 83880 | <1% | 1,282 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,237 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,022 | $1K |
| 84439 | <1% | 1,203 | $937.11 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 387 | $812.35 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,864 | $726.77 |
| 82570 | <1% | 124 | $537.91 | |
| 87430 | <1% | 308 | $524.77 | |
| 84703 | <1% | 3,874 | $520.84 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,578 | $506.82 |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 222 | $506.62 |
| 84702 | <1% | 3,146 | $478.28 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 16 | $472.26 |
| 85379 | <1% | 839 | $422.63 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 270 | $401.97 |
| 83605 | <1% | 787 | $389.74 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 71 | $225.05 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 622 | $219.80 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 307 | $190.41 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 439 | $144.84 |
| 80076 | <1% | 222 | $119.06 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 674 | $107.06 |
| 72040 | <1% | 18 | $98.67 | |
| 90715 | <1% | 81 | $75.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 818 | $69.05 |
| 85018 | <1% | 176 | $62.30 | |
| 80061 | Lipid panel | <1% | 212 | $59.60 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 762 | $58.39 |
| 96376 | <1% | 491 | $29.52 | |
| 82550 | <1% | 299 | $5.89 | |
| 87340 | <1% | 12 | $5.22 | |
| 84156 | <1% | 126 | $3.12 | |
| 85651 | <1% | 14 | $2.19 | |
| 0353U | 0% | 175 | $0.00 | |
| 73080 | 0% | 20 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 210 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 698 | $0.00 |
| 97803 | 0% | 141 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 169 | $0.00 |
| 84550 | 0% | 12 | $0.00 | |
| 87210 | 0% | 15 | $0.00 | |
| 87075 | 0% | 24 | $0.00 | |
| 86140 | 0% | 360 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 44 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 79 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 42 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 19 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 16 | $0.00 |
| 97802 | 0% | 14 | $0.00 | |
| 97162 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (CFO, SENIOR VP)
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Friends Behavioral Health System, LP | Philadelphia, PA | $9.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.